Giulia Biagioni

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy.

Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy.

Journal: International journal of cardiology

Published: March 11, 2026

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.

Journal: Circulation. Heart failure

Published: February 24, 2026

Single-Fluid Model for Rotating Annular Supersolids and Its Experimental Implications.

Single-Fluid Model for Rotating Annular Supersolids and Its Experimental Implications.

Journal: Physical review letters

Published: July 11, 2025

Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact.

Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact.

Journal: European heart journal

Published: February 26, 2025

Change in prevalence of ATTR variants in Italy: results from a national survey.

Change in prevalence of ATTR variants in Italy: results from a national survey.

Journal: European heart journal. Quality of care & clinical outcomes

Published: February 07, 2025

Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy: Traveling to the "Middle Earth".

Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy: Traveling to the "Middle Earth".

Journal: JACC. Advances

Published: October 25, 2024

Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis.

Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis.

Journal: International journal of cardiology

Published: September 10, 2024

The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis.

The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis.

Journal: Mayo Clinic proceedings

Published: July 08, 2024

Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray".

Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray".

Journal: Heart failure clinics

Published: June 06, 2024

Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy.

Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy.

Journal: Circulation. Heart failure

Published: March 19, 2024

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis.

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis.

Journal: European journal of heart failure

Published: February 29, 2024

Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies.

Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies.

Journal: JACC. Advances

Published: January 28, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026